ANGLE Plc (AGL):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ANGLE Plc (AGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9445
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease. Its product Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLE’s Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The company’s cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. It provides liquid biopsy (blood test) that enables the detection and investigation of mutations in the patient’s cancer for personalized cancer care. The company’s harvested CTCs have a range of applications such as diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring. It has operations in the US and the UK. ANGLE is headquartered in Guildford, the UK.

ANGLE Plc (AGL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9
ANGLE Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ANGLE Plc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
ANGLE Acquires Assets from Axela 11
Private Equity 12
ANGLE Raises USD2.5 Million in Private Placement of Shares 12
Partnerships 13
Angle Enters into Co-Development Agreement with Royal Philips 13
Angle Enters into Agreement with MD Anderson Cancer Center 14
Equity Offering 15
Angle Raises USD16.8 Million in Private Placement of Shares 15
ANGLE Raises USD3.7 Million in Private Placement of Shares 17
ANGLE Raises USD13.7 Million in Private Placement of Shares 18
ANGLE Plc – Key Competitors 19
ANGLE Plc – Key Employees 20
ANGLE Plc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Jul 25, 2018: ANGLE: Preliminary Results for the year ended 30 April 2018 22
Corporate Communications 26
Nov 01, 2018: Appointment of Dr Jan Groen as non-executive director 26
May 14, 2018: Angle Appoints Leading NHS Prostate Cancer Surgeon As Scientific Advisor 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
ANGLE Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9
ANGLE Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ANGLE Acquires Assets from Axela 11
ANGLE Raises USD2.5 Million in Private Placement of Shares 12
Angle Enters into Co-Development Agreement with Royal Philips 13
Angle Enters into Agreement with MD Anderson Cancer Center 14
Angle Raises USD16.8 Million in Private Placement of Shares 15
ANGLE Raises USD3.7 Million in Private Placement of Shares 17
ANGLE Raises USD13.7 Million in Private Placement of Shares 18
ANGLE Plc, Key Competitors 19
ANGLE Plc, Key Employees 20
ANGLE Plc, Other Locations 21

List of Figures
ANGLE Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ANGLE Plc (AGL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GW Pharmaceuticals Plc (GWP)-医療機器分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • Novartis India Ltd (500672):企業の財務・戦略的SWOT分析
    Summary Novartis India Ltd (Novartis), a subsidiary of Novartis AG, is a healthcare company that offers pharmaceuticals, generic medicine and eye care products. The company’s pharmaceutical division develops drugs in the therapeutic areas of bone and pain, calcium portfolio, gynecology, oncology and …
  • Altria Group Inc (MO):企業の財務・戦略的SWOT分析
    Altria Group Inc (MO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Confluent Medical Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Confluent Medical Technologies Inc (CMT), formerly Nitinol Devices and Components Inc is a medical device company that manufactures and markets nitinol devices and balloon catheters. The company provides products such as wire, strip, sheet, tubing and bar, among others. It offers development …
  • Chesapeake Energy Corp (CHK):企業の財務・戦略的SWOT分析
    Chesapeake Energy Corp (CHK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Natura Cosmeticos SA:戦略・SWOT・企業財務分析
    Natura Cosmeticos SA - Strategy, SWOT and Corporate Finance Report Summary Natura Cosmeticos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Courtagen Life Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company’s products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equip …
  • Wyndham Destinations, Inc.:企業の戦略・SWOT・財務情報
    Wyndham Destinations, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wyndham Destinations, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Luminex Corp (LMNX):企業の財務・戦略的SWOT分析
    Luminex Corp (LMNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • CoreSite Realty Corp (COR):企業の財務・戦略的SWOT分析
    CoreSite Realty Corp (COR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Center for Applied Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary Center for Applied Medical Research (CIMA), a subsidiary of University of Navarra is a medical research center that carries out research in the therapeutic areas of cardiovascular sciences, gene therapy and hepatology, oncology and neurosciences. The center also provides support services suc …
  • Peakdale Molecular Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Peakdale Molecular Ltd (Peakdale), a subsidiary of Concept Life Sciences Ltd, is a company that offers drug discovery services. It service portfolio offers services including drug discovery, nucleoside chemistry, materials chemistry and research support services. Peakdale offers research sup …
  • Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets …
  • VirnetX Holding Corp (VHC):企業の財務・戦略的SWOT分析
    Summary VirnetX Holding Corp (VirnetX) is a technology company that provides software and technology solutions for securing real-time communications. The company provides a gabriel connection technology which is an OEM software development kit, and is designed to secure real time communications over …
  • Nakanishi Inc (7716):企業の財務・戦略的SWOT分析
    Nakanishi Inc (7716) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Disco Corp (6146):企業の財務・戦略的SWOT分析
    Disco Corp (6146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chiome Bioscience Inc (4583)-製薬・医療分野:企業M&A・提携分析
    Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that offers research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating system …
  • Bonnier AB:企業の戦略的SWOT分析
    Bonnier AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • PepsiCo Inc:企業のM&A・事業提携・投資動向
    PepsiCo Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PepsiCo Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • HD Supply, Inc. (HDS):企業の財務・戦略的SWOT分析
    HD Supply, Inc. (HDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆